Moderate

Idiopathic recurrent angioedema (histaminergic, normal C1-INH)

Recurrent angioedema without urticaria or identifiable trigger · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Recurrent angioedema with a normal C1-inhibitor and no wheals, not explained by drugs or hereditary disease, is usually mast-cell (histamine) mediated and responds to antihistamines, distinguishing it from bradykinin-mediated forms. A subset is idiopathic and benefits from up-dosed antihistamine prophylaxis.

Figures & algorithms

Clinical features
Clinical features

Red flags

  • Tongue, uvular or laryngeal swelling with voice change or stridor
  • Rapidly progressive facial swelling
  • Angioedema unresponsive to antihistamines and steroids (suggests bradykinin cause)
  • Low C4/C1-INH or low C1q on testing
  • Weight loss or lymphadenopathy suggesting acquired deficiency

Assessment

Differential diagnosis

  • Hereditary angioedema (C1-INH deficiency)
  • Acquired C1-inhibitor deficiency (lymphoproliferative disease)
  • ACE-inhibitor / bradykinin-mediated angioedema
  • Chronic spontaneous urticaria with angioedema
  • NSAID-induced angioedema

Investigations

  • C4 level and C1-inhibitor level and function (normal here)
  • C1q (low suggests acquired deficiency)
  • FBC, tryptase, and ESR/CRP
  • Medication review for ACE-inhibitors, ARBs, NSAIDs, gliptins
  • Consider autoimmune/thyroid screen if associated urticaria

Management

  • Assess airway: lip, tongue, floor-of-mouth and laryngeal involvement take priority
  • If airway-threatening, treat as anaphylaxis with IM adrenaline and secure the airway early
  • Stop any ACE-inhibitor, ARB or NSAID and document causality
  • Give non-sedating H1 antihistamine as first-line for histaminergic attacks
  • Add a short corticosteroid course for severe or persistent facial/airway swelling
  • Send C4/C1-INH assays to exclude bradykinin-mediated disease before labelling idiopathic
  • Start regular up-dosed antihistamine prophylaxis for frequent recurrences
  • Refer to immunology/allergy for confirmation and omalizumab consideration if refractory

Drugs & doses

Cetirizine — 10 mg orally, up-dosed to 40 mg/day (up to 4x licensed dose) for prophylaxis
Chlorphenamine — 10 mg IV/IM for acute moderate attacks
Prednisolone — 40 mg orally once daily for 3-5 days for severe attacks
Adrenaline IM — 500 mcg (0.5 mL 1:1000) if airway compromise/anaphylaxis
Omalizumab — 300 mg SC every 4 weeks for refractory histaminergic angioedema (specialist)

Disposition

Discharge once airway is safe with an up-dosed antihistamine plan and allergy/immunology clinic referral; admit any airway-threatening attack.

Complications & pitfalls

  • Airway obstruction and asphyxia
  • Misdiagnosis delaying bradykinin-specific therapy
  • Recurrent presentations and reduced quality of life
  • Adverse effects of repeated corticosteroid courses
  • Anxiety and avoidance behaviour

Exam pearls

  • Angioedema that responds to antihistamines/steroids is histaminergic; failure to respond points to bradykinin-mediated disease needing icatibant or C1-INH
  • Always exclude ACE-inhibitors even years into therapy — onset can be delayed
  • Normal C4 between attacks makes hereditary angioedema unlikely but a low C4 warrants full complement work-up
  • Idiopathic is a diagnosis of exclusion after complement testing

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.